Furthermore, MiR-181b may increase chemosensitivity to DDP and suppress the invasion and metastasis of NSCLC cells through directly targeting the TGFβR1 signaling pathway. This evidence concerns the gene TGFBR1 and non-small cell lung carcinoma.